SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/7438A105503DD982D7BDCE904225439DD0FAA88F092C0C475A4CB07256E690EE27A74B60CDE0D05FCB5FEE7D8BDDE123>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/7438A105503DD982D7BDCE904225439DD0FAA88F092C0C475A4CB07256E690EE27A74B60CDE0D05FCB5FEE7D8BDDE123
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/7438A105503DD982D7BDCE904225439DD0FAA88F092C0C475A4CB07256E690EE27A74B60CDE0D05FCB5FEE7D8BDDE123
http://www.w3.org/2000/01/rdf-schema#comment
"The diffuse and strong nuclear immunoreactivity of PELP1 in most cases suggests that PELP1 may be a molecular target for the treatment of triple-negative breast carcinoma"
xsd:string
http://purl.uniprot.org/uniprot/#_44BDB3EA62118DA057657ECFD0BA98C10F435AB275DE490AF4BBC7035C000B02468EE2C08C0E819A52F54430B80A199E
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/7438A105503DD982D7BDCE904225439DD0FAA88F092C0C475A4CB07256E690EE27A74B60CDE0D05FCB5FEE7D8BDDE123
http://purl.uniprot.org/uniprot/Q8IZL8
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/7438A105503DD982D7BDCE904225439DD0FAA88F092C0C475A4CB07256E690EE27A74B60CDE0D05FCB5FEE7D8BDDE123
http://purl.uniprot.org/uniprot/#_Q8IZL8-mappedCitation-26428280
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/7438A105503DD982D7BDCE904225439DD0FAA88F092C0C475A4CB07256E690EE27A74B60CDE0D05FCB5FEE7D8BDDE123